P119 T-bet+ B cells can serve as prognostic and therapeutic tools for human systemic lupus erythematosus
Panayotis Verginis,
Maria Trachana,
Christina Adamichou,
Anna Taparkou,
Dimitrios Boumpas,
Athanasios Sachinidis,
Sofoklis Keisaris,
George Gavriilidis,
Alexandros Garyfallos
Affiliations
Panayotis Verginis
4Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece
Maria Trachana
8 First Department of Pediatrics, Pediatric Immunology and Rheumatology Referral Center, Hippokration General Hospital, Aristotle University, Thessaloniki, Greece
Christina Adamichou
Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Crete, Greece
Anna Taparkou
4 Paediatric Immunology and Rheumatology Referral Center, First Department of Paediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
Dimitrios Boumpas
1Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens
Athanasios Sachinidis
14th Dept. of Internal Medicine, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Sofoklis Keisaris
3Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thermi, Thessaloniki, Greece
George Gavriilidis
3Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thermi, Thessaloniki, Greece
Alexandros Garyfallos
14th Dept. of Internal Medicine, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
